J Otolaryngol Ophthalmol Shandong Univ ›› 2017, Vol. 31 ›› Issue (2): 116-120.doi: 10.6040/j.issn.1673-3770.0.2016.293

Previous Articles     Next Articles

Advances in clinical diagnosis and treatment of sinonasal mucosal malignant melanoma.

  

  1. 1. Bengbu Medical College, Bengbu 233030, Anhui, China;2. Department of Otolaryngology Heck and Neck Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, Anhui, China
  • Received:2016-06-29 Online:2017-04-16 Published:2017-04-16

PDF (PC)

825

Abstract: Sinonasal mucosal malignant melanoma(SMMM)is a rare sinonasal malignant tumor. Due to the atypical symptoms, most patients were diagnosed as the advanced stage, and the 5-year survival rate is limited to 20%-30%. Pathology is the gold standard for diagnosis. Black pigment particles found in the tissue cells can help the diagnosis; for the non-pigmented melanoma, immunohistochemistry can help to identify the diagnosis. Compared with Ballantyne staging, the 7th edition of American Joint Committee on Cancer(AJCC)malignant melanoma tumor node metastasis(mmTNM)staging may be more suitable for SMMM. At present, the surgical treatment is the first choice for early SMMM, and a comprehensive treatment method, such as surgery combined with radiotherapy and biochemotherapy is favorable to improving the survival rate of patients.

Key words: Malignant melanoma, Diagnosis, Sinonasal, Neoplasms staging, Therapy

CLC Number: 

  • R739.62
[1] Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma[J]. Laryngoscope, 2011, 121(9):2026-2033.
[2] López F, Rodrigo JP, Cardesa A, et al. Update on primary head and neck mucosal melanoma[J]. Head Neck, 2016, 38(1):147-155.
[3] Pittaka M, Kardamakis D, Spyropoulou D. Comparison of international guidelines on mucosal melanoma of the head and neck: a comprehensive review of the role of radiation therapy[J]. In vivo, 2016, 30(3):165-170.
[4] Vandenhende C, Leroy X, Chevalier D, et al. Sinonasal mucosal melanoma: retrospective survival study of 25 patients[J]. Laryngol Otol, 2012, 126(2):147 -51.
[5] Gilain L, Houette A, Montalban A, et al. Mucosal melanoma of the nasal cavity and paral nasal sinuses[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2014, 131(6):365-369.
[6] Gavriel H, McArthur G, Sizeland A, et al. Review: mucosal melanoma of the head and neck[J]. Melanoma Research, 2011, 21(4):257-266.
[7] Shakhova O, Zingg D, Schaefer SM, et al. SOX10 promotes the formation and maintenance of giant congenital naevi and melanoma[J]. Nat Cel Biol, 2012, 14(8):882 -890.
[8] Liu HG, Kon MX, Yao Q, et al. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population[J]. Head and Neck Pathol, 2012, 6(4): 401-408.
[9] Ballantyne AJ. Malignant melanoma of skin of head and neck. An analysis of 405 cases[J]. Am J Surg, 1970, 120(4): 425-431.
[10] Michel J, Perret-Court A, Fakhry N, et al. Sinonasal mucosal melanomas: The prognostic value of tumor classifications[J]. Head & Neck, 2014, 36(3):311-316.
[11] Prasad ML, Patel SG, Huvos AG, et al. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I(lymph node-negative)tumors[J]. Cancer, 2004, 100(8):1657-1664.
[12] Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer, 2010: 347-376.
[13] Greene FL. American joint committee on cancer, american cancer society. AJCC cancer staging manual[M]. 6th ed. New York, Springer, 2002.
[14] Samstein RM, Carvajal RD, Postow MA, et al. Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response[J]. Head Neck, 2016, 38(9):1310-1317.
[15] Kuauhyama LO, Madeleine AR, Verónica VV, et al. Comparative study between two different staging systems(AJCC TNM VS BALLANTYNES)for mucosal melanomas of the Head & Neck[J]. Med Oral Patol Oral Cir Bucal, 2016, 21(4):e425-e430.
[16] Shuman AG, Light E, Olsen SH, et al. Mucosal melanoma of the head and neck: predictors of prognosis[J]. Arch Otolaryngol Head Neck Surg, 2011, 137(4):331-337.
[17] Koivunen P, Bäck L, Pukkila M, et al. Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma[J]. Laryngoscope, 2012, 122(8):1734-1738.
[18] Ma R, Li Y, Li J, et al. Clinical analysis of 6 cases with sinonasal malignant melanoma[J]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2015, 29(9):828-831.
[19] 吴云腾, 任国欣, 孙沫逸, 等. 中国头颈黏膜黑色素瘤临床诊治专家共识[J]. 中国口腔颌面外科杂志, 2015, 13(3):262-268. WU Yunteng, REN Guoxin, SUN Moyi, et al. Chinese expert consensus document on head and neck mucosal malignant melanoma[J]. Chin J Oral Maxillofa Surg, 2015, 13(3):262-268.
[20] CSCO黑色素瘤专家委员会. 中国黑色素瘤诊治指南(2013版)[M]. 北京: 人民卫生出版社, 2013: 8-38.
[21] Swegal W, Koyfman S, Scharpf J, et al. Endoscopic and open surgical approaches to locally advanced sinonasal melanoma comparing the therapeutic benefits[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(9):840-845.
[22] Yu H, Liu G. Clinical analysis of 29 cases of nasal mucosal malignant melanoma[J]. Oncol Lett, 2015, 10(2):1166-1170.
[23] Li W, Yu YL, Wang HL, et al. Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis[J]. BMC Cancer, 2015, 15:758.
[24] Meng XJ, Ao HF, Huang WT, et al. Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma[J]. BMC Cancer, 2014, 14:608.
[25] Lund VJ, Chisholm EJ, Howard DJ, et al. Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection[J]. Rhinology, 2012, 50(2):203-210.
[26] Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center[J]. Cancer, 2010, 116(9):2215-2223.
[27] Marta GN, Silva V, Andrade CH, et al. Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis[J]. Radiother Oncol, 2014, 110(1):9-15.
[28] Askoxylakis V, Hegenbarth P, Timke C, et al. Intensity modulated radiation therapy(IMRT)for sinonasal tumors: a single center long-term clinical analysis[J]. Radia Oncol, 2016, 11:17.
[29] Gore MR, Zanation AM. Survival in sinonasal melanoma: a meta-analysis[J]. J Neurol Surg Skull Base, 2012, 73(3):157-162.
[30] 侯金程, 杨丽辉, 杨琨, 等. 树突状细胞疫苗联合细胞因子诱导的杀伤细胞治疗鼻腔及鼻窦恶性黑色素瘤的近期疗效观察[J]. 临床医学, 2010, 30(1):16-18. HOU Jincheng, YANG Lihui, YANG Kun, et al. Study of the treatment of sinonasal malignant melanoma with DC and CIK[J]. Clin Med, 2010, 30(1):16-18.
[31] 杜楠, 李留树, 肖文华, 等. 生物化疗、化疗或生物疗法用于治疗恶性黑色素瘤的回顾性分析[J]. 中国癌症杂志, 2008, 18(8):573-576. DU Nan, LI Liushu, XIAO Wenhua, et al. Retrospective analysis of biochemotherapy versus chemotherapy or biotherapy for metastatic melanoma[J]. Chin Oncol, 2008, 18(8):573-576.
[32] Bollag G, Tsai J, Zhang J, et al. Vemurafenib: the first drug approved for BRAF-mutant cancer[J]. Nat Rev Drug Discov, 2012, 11(11):873-886.
[33] Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma[J]. N Engl J Med, 2010, 363(8):711-723.
[34] Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation[J]. N Engl J Med, 2011, 364(26):2507-2516.
[35] Guo J, Si L, Kong Y, et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification[J]. J Clin Oncol, 2011, 29(21):2904-2909.
[36] Swaika A, Hammond WA, Joseph RW, et al. Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy[J]. Mol Immunol, 2015, 67(2Pt A):4 -17.
[1] WANG Tan, WU Ke, LI Lianqing, GONG Lili. Factors associated with systemic adverse reactions after subcutaneous immunotherapy injections and treatment options [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 71-74.
[2] WU Jing, LIU Yehai. Targeted therapy for head and neck squamous cell carcinoma [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 97-102.
[3] ZHU Mingjuan, XING Kai, KANG Zefeng, LIU Jian. Diagnosis and treatment of thyroid-associated ophthalmopathy [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 110-113.
[4] SUN Shujuan, SHI Lei, FAN Zhaomin, SHI Guanggang. Nasal related somatoform disorders [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 32-36.
[5] WU Xiangping. Influence of patient management on the clinical effect of sublingual dermatophagoides farinae drops in patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 68-72.
[6] QIN Gang, LIANG Zhuoping. Status of immunotherapy in allergic fungal rhinosinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 23-26.
[7] CHEN Ming, YU Xuefei. Opinions on the treatment of chronic rhinosinusitis with allergic rhinitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 18-22.
[8] ZHONG Jianwen, LIU Dabo, LUO Xiangqian, HUANG Zhenyun, QIU Shuyao, CHENG Chao, YANG Liqiang, YI Xinhua, ZENG Jinhong. The application of wearable devices in the diagnosis of children obstructive sleep apnea [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 30-33.
[9] WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106.
[10] LI Qiaoli, LI Chao, WANG Wei, CAI Yongcong, SUN Ronghao, ZHOU Yuqiu, SHUI Chunyan, HUANG Lu, TU Jing. Primary squamous cell carcinoma of the parotid gland with recurrence and invasion of lateral skull base after radiotherapy and chemotherapy: one case report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 87-88.
[11] CHEN Hong, CAO Huiling, DOU Xin, GAO Xia. Small cell neuroendocrine carcinoma in the right nasal cavity: a report of one case and a literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 89-92.
[12] WANG Zhixiang, XUE Kai, WEI Ning, HAN Shuang, JIN Chunshun.. A case of recurrent laryngeal nerve schwannoma misdiagnosed as a thyroid tumor. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 33-35.
[13] JING Shanglin.. Diagnosis and treatment of upper airway cough syndrome in children. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 87-91.
[14] PAN Yongjie, SUN Guochen, ZANG Chuanshan. Granular cell tumor in the larynx: a report of four cases and a literature review. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 104-106.
[15] SUN Shasha, QIU Jie, ZANG Chuanshan, SUN Yan. Behcets disease misdiagnosed as acute epiglottitis: a report of two cases. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 107-109.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] ZHAO Li-min, NI Kun, WU Jia-li, CHEN Shu-mei, LI Xiao-yan. Etiology and treatment of inspiratory laryngeal stridor in infants[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 49 -51 .
[2] SHI Chun-sheng1, ZHANG Qing-quan2， WANG Qiang2, SUN Yan2, GE Chang-yi1. Application of flaps in the reconstruction of soft palate defects[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 86 -88 .
[3] ZHANG Ling1, SUN Chuan-yi1, XU An-ting2. 1 case of petrous apex cholesteatoma deafness patients[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 93 -94 .
[4] . [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 1 -3 .
[5] LUO Hui-xiu, FAN Chun-tao, DENG Yan-hua. Therapeutic effects of adenoidectomy and tonsillectomy in children with obstructive sleep apnea hypopnea syndrome[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 17 -20 .
[6] HAO Ying-juan1, YANG Qing-song2, ZHOU Yue-hua2, YI Sheng-ping1， ZHAI Chang-bin2. Characteristics of thin corneal flaps created with Wavelight FS200 femtosecond laser[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 26 -31 .
[7] WEN Hua-ming1, LI Hai-xiang2. Application of trianglar function method to calculate intra ocular lens power after myopic laser in situ keratomileusis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 74 -76 .
[8] ZHU Jian， HE Qing-qing， ZHENG Lu-ming， FAN Zi-yi， ZHAO Guo-wei， HOU Lei， SHI Hou-bin. Clinical analysis for 57 re-operational cases of differentiated thyroid cancer[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 9 -12 .
[9] LI Shao-hua, SUN Yi-fan, LU Biao-qing. Application of double vascularized soft tissue flap in open radical mastoidectomy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 6 -7 .
[10] WEI Xi-jian1, YIN Rui-lan2, GUO Xing3. Expression of a proliferation-inducing ligand in laryngeal squamous cell carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 14 -16 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd